ES502080A0 - Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina - Google Patents

Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina

Info

Publication number
ES502080A0
ES502080A0 ES502080A ES502080A ES502080A0 ES 502080 A0 ES502080 A0 ES 502080A0 ES 502080 A ES502080 A ES 502080A ES 502080 A ES502080 A ES 502080A ES 502080 A0 ES502080 A0 ES 502080A0
Authority
ES
Spain
Prior art keywords
choline
procedure
preparation
phospholipidic compositions
phospholipidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502080A
Other languages
English (en)
Spanish (es)
Other versions
ES8207184A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Made Italiana SRL
Original Assignee
Made Italiana SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana SRL filed Critical Made Italiana SRL
Publication of ES8207184A1 publication Critical patent/ES8207184A1/es
Publication of ES502080A0 publication Critical patent/ES502080A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES502080A 1980-04-18 1981-04-15 Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina Granted ES502080A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (2)

Publication Number Publication Date
ES8207184A1 ES8207184A1 (es) 1982-09-01
ES502080A0 true ES502080A0 (es) 1982-09-01

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502080A Granted ES502080A0 (es) 1980-04-18 1981-04-15 Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina

Country Status (15)

Country Link
US (1) US4386077A (cs)
AT (1) AT376366B (cs)
AU (1) AU544469B2 (cs)
BE (1) BE890796A (cs)
CH (1) CH652026A5 (cs)
DE (1) DE3115080C2 (cs)
DK (1) DK173081A (cs)
ES (1) ES502080A0 (cs)
FR (1) FR2480603B1 (cs)
GB (1) GB2074445B (cs)
IN (1) IN156105B (cs)
IT (1) IT1207106B (cs)
NL (1) NL8101899A (cs)
SE (1) SE447449B (cs)
ZA (1) ZA812600B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
DE69634773T2 (de) * 1995-03-06 2006-05-04 Interneuron Pharmaceuticals, Inc., Lexington Verminderung des infarktausmasses unter verwendung von citicolin
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2001247474A1 (en) * 2000-03-16 2001-09-24 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
EP1604671A4 (en) * 2003-02-26 2006-03-29 Kyowa Hakko Kogyo Kk MUSCLE TREATMENT AND MEANS FOR PREVENTING OR TREATING MUSCLE WEAKNESS
EP1765075A4 (en) * 2004-06-10 2010-11-10 Mclean Hospital Corp PYRIMIDINES, AS FORM. uridine; IN THE TREATMENT OF PATIENTS WITH MANIC-DEPRESSIVE PSYCHOSIS
US20090215714A1 (en) * 2004-06-10 2009-08-27 Perry Renshaw Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (cs) * 1969-08-04 1973-12-07
JPS4886869A (cs) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
IT1207106B (it) 1989-05-17
DE3115080A1 (de) 1982-02-25
SE447449B (sv) 1986-11-17
AU6994581A (en) 1981-10-22
ATA172081A (de) 1984-04-15
CH652026A5 (it) 1985-10-31
ES8207184A1 (es) 1982-09-01
BE890796A (fr) 1982-02-15
US4386077A (en) 1983-05-31
DK173081A (da) 1981-10-19
GB2074445A (en) 1981-11-04
AT376366B (de) 1984-11-12
DE3115080C2 (de) 1986-10-16
AU544469B2 (en) 1985-05-30
IT8048454A0 (it) 1980-04-18
FR2480603B1 (fr) 1985-07-12
FR2480603A1 (fr) 1981-10-23
ZA812600B (en) 1982-04-28
IN156105B (cs) 1985-05-18
SE8102456L (sv) 1981-10-19
GB2074445B (en) 1983-09-07
NL8101899A (nl) 1981-11-16

Similar Documents

Publication Publication Date Title
MX160712A (es) Procedimiento para la preparacion de composiciones orales de dipiridamol
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
ES500256A0 (es) Procedimiento para la preparacion de fosfolipidos polimeri- zables
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
ES502080A0 (es) Procedimiento para la preparacion de composiciones fosfoli- pidicas de colina
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
ES524997A0 (es) Procedimiento para la preparacion de derivados de la desoxiuridina
MX6305E (es) Procedimiento para la preparacion de 3-0(beta-d-glucouronopiranosil)-soyasapogenol b
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
AR230570A1 (es) Procedimiento para la preparacion de nuevas composiciones farmaceuticas antiulcerosas
ES526538A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas
MX6294E (es) Procedimiento mejorado para la preparacion de l-alfa-gliceril fosforil colina
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES487362A0 (es) Procedimiento para la preparacion de composiciones mixtas decetoperoxidos
AR231531A1 (es) Esteres de acidos alquiliden-,cicloalquiliden-e indanilidencarbacicos,procedimento para su preparacion y composicion y composiciones que los contienen
MX6707E (es) Procedimiento para la preparacion de n(1-alil-2-pirrolidinilmetil)-2-metoxi-4-amino-5-metil-sulfamoil-benzamida
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES541713A0 (es) Procedimiento para la preparacion de sales de diarilyodosilo
ES527552A0 (es) Procedimiento para la preparacion de acridanona
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES525034A0 (es) Procedimiento para la preparacion de derivados de 28-metil-brassinolidas